1. Home
  2. GLU vs CDXS Comparison

GLU vs CDXS Comparison

Compare GLU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$21.00

Market Cap

119.8M

Sector

Finance

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.17

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
CDXS
Founded
2004
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
119.8M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
GLU
CDXS
Price
$21.00
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.4K
1.1M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$52,932,000.00
Revenue This Year
N/A
$15.64
Revenue Next Year
N/A
$5.23
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.61
$1.22
52 Week High
$15.40
$4.46

Technical Indicators

Market Signals
Indicator
GLU
CDXS
Relative Strength Index (RSI) 81.69 33.59
Support Level $19.57 $1.24
Resistance Level $20.31 $1.36
Average True Range (ATR) 0.25 0.14
MACD 0.06 -0.02
Stochastic Oscillator 69.85 0.00

Price Performance

Historical Comparison
GLU
CDXS

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: